Evidence map›Paper›PMID 39162511›Full record

ArticleMicrobiology spectrum2024

Genotypic characterization and antimicrobial susceptibility of human

Pablo Fernández-Palacios, Fátima Galán-Sánchez, Carlos S Casimiro-Soriguer, Estefanía Jurado-Tarifa, Federico Arroyo, María Lara, J Alberto Chaves, Joaquín Dopazo, Manuel A Rodríguez-Iglesias

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Serine protease HtrA promotesScience advances · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pablo Fernández-PalaciosUGC Microbiología, Hospital Universitario Puerta del Mar, Cádiz, Spain.ORCID 0000-0002-4257-2889
Fátima Galán-SánchezUGC Microbiología, Hospital Universitario Puerta del Mar, Cádiz, Spain.ORCID 0000-0003-0101-6701
Carlos S Casimiro-SoriguerPlataforma Andaluza de Medicina Computacional, Fundación Pública Andaluza Progreso y Salud, Sevilla, Spain.
Estefanía Jurado-TarifaInstituto de Investigación e Innovación Biomédica de Cádiz (INIBICA), Hospital Universitario Puerta del Mar, Cádiz, Spain.
Federico ArroyoUGC Microbiología, Hospital Universitario Puerta del Mar, Cádiz, Spain.
María LaraPlataforma Andaluza de Medicina Computacional, Fundación Pública Andaluza Progreso y Salud, Sevilla, Spain.
J Alberto ChavesSubdirección de Protección de la Salud, Consejería de Salud y Familias, Sevilla, Spain.
Joaquín DopazoPlataforma Andaluza de Medicina Computacional, Fundación Pública Andaluza Progreso y Salud, Sevilla, Spain.
Manuel A Rodríguez-IglesiasUGC Microbiología, Hospital Universitario Puerta del Mar, Cádiz, Spain.ORCID 0000-0002-7097-9651

Funding

Ministerio de Ciencia, Innovación y Universidades (MCIU) FJC2021-046546-I
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsCampylobacter InfectionsCampylobacter jejuniGenotypeMicrobial Sensitivity TestsPhylogenyAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCiprofloxacinDrug Resistance, BacterialErythromycinFemaleAnti-Bacterial AgentsCiprofloxacinErythromycinTetracyclineantimicrobial resistanceCampylobacter jejuniepidemiologyvirulomewhole-genome sequencing

Identifiers

PMID39162511
PMCPMC11449230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.